Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease

The response by vaccine developers to the COVID-19 pandemic has been extraordinary with effective vaccines authorized for emergency use in the United States within 1 year of the appearance of the first COVID-19 cases. However, the emergence of SARS-CoV-2 variants and obstacles with the global rollou...

Descripción completa

Detalles Bibliográficos
Autores principales: Davenport, Bennett J., Catala, Alexis, Weston, Stuart M., Johnson, Robert M., Ardanuy, Jeremy, Hammond, Holly L., Dillen, Carly, Frieman, Matthew B., Catalano, Carlos E., Morrison, Thomas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135756/
https://www.ncbi.nlm.nih.gov/pubmed/35618725
http://dx.doi.org/10.1038/s41541-022-00481-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135756/
https://www.ncbi.nlm.nih.gov/pubmed/35618725
http://dx.doi.org/10.1038/s41541-022-00481-1

Ejemplares similares